GMDAQ — Gamida Cell Share News
0.000.00%
- $2.62m
- $35.61m
- $1.78m
Brief: Stonepine Capital Management, LLC Reports 7.9% Passive Stake In Gamida Cell Ltd. As Of Aug 15- SEC Filing
Gamida Cell Ltd reports results for the quarter ended in June - Earnings Summary
Brief: Gamida Cell Ltd. Q2 net income USD -31.7 million
Gamida Cell Ltd expected to post a loss of 19 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
Gamida Cell's US-listed shares down after naming new finance chief
Brief: Gamida Cell Appoints Terry Coelho As CFO
Gamida Cell Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Gamida Cell Reports First Quarter 2023 Financial Results And Provides Company Update
Gamida Cell Ltd expected to post a loss of 27 cents a share - Earnings Preview
Gamida Cell drops on pricing stock deal
Brief: Gamida Cell Announces Pricing Of $23 Million Public Offering Of Securities
U.S. STOCKS ON THE MOVE-Nvidia, Nuvei, Boeing
U.S. STOCKS ON THE MOVE-SAB Biotherapeutics, Blue Star Foods, Bellus Health
U.S. STOCKS ON THE MOVE-Johnson & Johnson, U.S. banks, Lockheed Martin
U.S. STOCKS ON THE MOVE-Bellus Health, Gamida Cell, Avenue Therapeutics
Gamida Cell extends gains as FDA approves co's blood cancer therapy
Brief: Gamida Cell's Therapy In Blood Cancer Treatment Receives FDA Approval